RecruitingNot applicableNCT06307171

Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Intervention
In-house Western blot, specific for Leishmania(diagnostic_test)
Enrollment
170 target
Eligibility
18 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06307171 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials